{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T07:58:26Z","timestamp":1762761506768},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T00:00:00Z","timestamp":1537315200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s10354-018-0654-y","type":"journal-article","created":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T11:57:01Z","timestamp":1537358221000},"page":"33-40","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Neurological complications of systemic tumor therapy"],"prefix":"10.1007","volume":"169","author":[{"given":"Wolfgang","family":"Grisold","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"L\u00f6scher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Grisold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,19]]},"reference":[{"issue":"1","key":"654_CR1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/neuonc\/nox115","volume":"20","author":"AM Zukas","year":"2018","unstructured":"Zukas AM, Schiff D. Neurological complications of new chemotherapy agents. Neuro-oncology. 2018;20(1):24\u201336.","journal-title":"Neuro-oncology"},{"key":"654_CR2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fonc.2012.00073","volume":"2","author":"D Greene-Schloesser","year":"2012","unstructured":"Greene-Schloesser D, et al. Radiation-induced brain injury: a review. Front Oncol. 2012;2:73.","journal-title":"Front Oncol"},{"key":"654_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2017.12.003","author":"S Sharma","year":"2017","unstructured":"Sharma S, et al. Effect of prophylactic cranial irradiation on overall survival in metastatic small-cell lung cancer: a propensity score-matched analysis. Clin Lung Cancer. 2017; https:\/\/doi.org\/10.1016\/j.cllc.2017.12.003 .","journal-title":"Clin Lung Cancer"},{"issue":"4","key":"654_CR4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0736-5748(94)90081-7","volume":"12","author":"J Radcliffe","year":"1994","unstructured":"Radcliffe J, et al. Cognitive deficits in long-term survivors of childhood medulloblastoma and other noncortical tumors: age-dependent effects of whole brain radiation. Int J Dev Neurosci. 1994;12(4):327\u201334.","journal-title":"Int J Dev Neurosci"},{"issue":"2","key":"654_CR5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cllc.2016.09.007","volume":"18","author":"R Zhao","year":"2017","unstructured":"Zhao R, et al. Hippocampal-sparing whole-brain radiotherapy for lung cancer. Clin Lung Cancer. 2017;18(2):127\u201331.","journal-title":"Clin Lung Cancer"},{"key":"654_CR6","doi-asserted-by":"crossref","first-page":"916","DOI":"10.12659\/AJCR.900537","volume":"17","author":"R Mehanna","year":"2016","unstructured":"Mehanna R, Jimenez-Shahed J, Itin I. Three cases of Levodopa-resistant Parkinsonism after radiation therapy. Am J Case Rep. 2016;17:916\u201320.","journal-title":"Am J Case Rep"},{"issue":"17","key":"654_CR7","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1016\/j.ejca.2015.08.009","volume":"51","author":"RS Pompe","year":"2015","unstructured":"Pompe RS, von Bueren SO, Mynarek M, von Hoff K, Friedrich C, Kwiecien R, Treulieb W, Lindow C, Deinlein F, Fleischhack G, Kuehl J, Rutkowski S. Intraventricular methotrexate as part of primary therapy for children with infant and\/or metastatic medulloblastoma: feasibility, acute toxicity and evidence for efficacy. Eur J Cancer. 2015;51(17):2634\u201342. https:\/\/doi.org\/10.1016\/j.ejca\u00a0.2015.08.009.","journal-title":"Eur J Cancer"},{"issue":"1","key":"654_CR8","first-page":"e2037","volume":"10","author":"YP Song","year":"2018","unstructured":"Song YP, Colaco RJ. Radiation necrosis\u2014a growing problem in a\u00a0case of brain metastases following whole brain radiotherapy and stereotactic radiosurgery. Cureus. 2018;10(1):e2037.","journal-title":"Cureus"},{"issue":"2","key":"654_CR9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11060-013-1059-9","volume":"112","author":"AH Shah","year":"2013","unstructured":"Shah AH, et\u00a0al. Discriminating radiation necrosis from tumor progression in gliomas: a\u00a0systematic review what is the best imaging modality? J\u00a0Neurooncol. 2013;112(2):141\u201352.","journal-title":"J Neurooncol"},{"issue":"1","key":"654_CR10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.radonc.2013.08.009","volume":"110","author":"DM Gujral","year":"2014","unstructured":"Gujral DM, et al. Radiation-induced carotid artery atherosclerosis. Radiother Oncol. 2014;110(1):31\u20138.","journal-title":"Radiother Oncol"},{"issue":"3","key":"654_CR11","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jvs.2016.11.024","volume":"65","author":"KM Bond","year":"2017","unstructured":"Bond KM, et\u00a0al. Endovascular treatment of carotid blowout syndrome. J\u00a0Vasc Surg. 2017;65(3):883\u20138.","journal-title":"J Vasc Surg"},{"issue":"5","key":"654_CR12","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/cncr.29801","volume":"122","author":"CM Tully","year":"2016","unstructured":"Tully CM, et\u00a0al. The high incidence of vascular thromboembolic events in patients with metastatic or unresectable urothelial cancer treated with platinum chemotherapy agents. Cancer. 2016;122(5):712\u201321.","journal-title":"Cancer"},{"issue":"1","key":"654_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.2008.01059.x","volume":"119","author":"W Grisold","year":"2009","unstructured":"Grisold W, Oberndorfer S, Struhal W. Stroke and cancer: a\u00a0review. Acta Neurol Scand. 2009;119(1):1\u201316.","journal-title":"Acta Neurol Scand"},{"issue":"11","key":"654_CR14","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2165\/00002018-200831110-00003","volume":"31","author":"KI Sweiss","year":"2008","unstructured":"Sweiss KI, Beri R, Shord SS. Encephalopathy after high-dose Ifosfamide: a\u00a0retrospective cohort study and review of the literature. Drug Saf. 2008;31(11):989\u201396.","journal-title":"Drug Saf"},{"issue":"1 Suppl 1","key":"654_CR15","first-page":"39","volume":"25","author":"AD Valentine","year":"1998","unstructured":"Valentine AD, et al. Mood and cognitive side effects of interferon-alpha therapy. Semin Oncol. 1998;25(1 Suppl 1):39\u201347.","journal-title":"Semin Oncol"},{"key":"654_CR16","first-page":"903","volume-title":"Handbook of clinical neurology 3rd series","author":"HB Newton","year":"2012","unstructured":"Newton HB. Neurological complications of chemotherapy to the central nervous system. In: Grisold W, Soffietti R, editors. Handbook of clinical neurology 3rd series. Vol. 105. 2012. pp.\u00a0903\u201316."},{"issue":"8","key":"654_CR17","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.neubiorev.2013.04.015","volume":"37","author":"M Sim\u00f3a","year":"2013","unstructured":"Sim\u00f3a M, Rif\u00e0-Rosa X, Rodriguez-Fornellsa A, Brunab J, More S. Chemobrain: a systematic review of structural and functional neuroimaging studies. Neurosci Biobehav Rev. 2013;37(8):1311\u201321.","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"654_CR18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.14336\/AD.2015.1022","volume":"7","author":"AM Gaman","year":"2016","unstructured":"Gaman AM, et al. The role of oxidative stress in etiopathogenesis of chemotherapy induced cognitive impairment (CICI)-\u201cChemobrain\u201d. Aging Dis. 2016;7(3):307\u201317.","journal-title":"Aging Dis"},{"key":"654_CR19","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.nicl.2017.12.032","volume":"18","author":"M Simo","year":"2018","unstructured":"Simo M, et al. Performance monitoring in lung cancer patients pre- and post-chemotherapy using fine-grained electrophysiological measures. Neuroimage Clin. 2018;18:86\u201396.","journal-title":"Neuroimage Clin"},{"key":"654_CR20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.phrs.2017.01.001","volume":"117","author":"X Ren","year":"2017","unstructured":"Ren X, St. Clair DK, Butterfield DA. Dysregulation of cytokine mediated chemotherapy induced cognitive impairment. Pharmacol Res. 2017;117:267\u201373.","journal-title":"Pharmacol Res"},{"issue":"4","key":"654_CR21","first-page":"184","volume":"1","author":"C Kamiya-Matsuoka","year":"2014","unstructured":"Kamiya-Matsuoka C, et al. Primary brain tumors and posterior reversible encephalopathy syndrome. Neurooncol Pract. 2014;1(4):184\u201390.","journal-title":"Neurooncol Pract"},{"key":"654_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-220429","author":"C Mescher","year":"2017","unstructured":"Mescher C, Slungaard A. Posterior reversible encephalopathy syndrome in a\u00a0postpartum woman with acute lymphoblastic leukaemia after intrathecal methotrexate. BMJ Case Rep. 2017; https:\/\/doi.org\/10.1136\/bcr-2017-220429 .","journal-title":"BMJ Case Rep."},{"issue":"2","key":"654_CR23","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s10637-017-0521-5","volume":"36","author":"S Deguchi","year":"2018","unstructured":"Deguchi S, et al. Posterior reversible encephalopathy syndrome (PRES) induced by pazopanib, a\u00a0multi-targeting tyrosine kinase inhibitor, in a\u00a0patient with soft-tissue sarcoma: case report and review of the literature. Invest New Drugs. 2018;36(2):346\u20139.","journal-title":"Invest New Drugs"},{"issue":"Suppl 1","key":"654_CR24","first-page":"170","volume":"15","author":"O Gheith","year":"2017","unstructured":"Gheith O, et al. Sirolimus-induced combined posterior reversible encephalopathy syndrome and lymphocytic pneumonitis in a\u00a0renal transplant recipient: case report and review of the literature. Exp Clin Transplant. 2017;15(Suppl 1):170\u20134.","journal-title":"Exp Clin Transplant"},{"issue":"4","key":"654_CR25","doi-asserted-by":"crossref","first-page":"107327481772990","DOI":"10.1177\/1073274817729901","volume":"24","author":"C Bohra","year":"2017","unstructured":"Bohra C, Sokol L, Dalia S. Progressive multifocal leukoencephalopathy and monoclonal antibodies: a review. Cancer Control. 2017;24(4):1073274817729901.","journal-title":"Cancer Control"},{"key":"654_CR26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ctrv.2016.02.001","volume":"44","author":"L Spain","year":"2016","unstructured":"Spain L, Diem S, Larkin J. Management of toxicities of immune checkpoint inhibitors. Cancer Treat Rev. 2016;44:51\u201360.","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"654_CR27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4103\/IJCIIS.IJCIIS_15_17","volume":"7","author":"S Kuru","year":"2017","unstructured":"Kuru S, Khan N, Shaaban H. Acute hypophysitis secondary to nivolumab immunotherapy in a\u00a0patient with metastatic melanoma. Int J Crit Illn Inj Sci. 2017;7(3):177\u201380.","journal-title":"Int J Crit Illn Inj Sci"},{"issue":"11","key":"654_CR28","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2217\/imt-2017-0056","volume":"9","author":"GJ McGinnis","year":"2017","unstructured":"McGinnis GJ, Raber J. CNS side effects of immune checkpoint inhibitors: preclinical models, genetics and multimodality therapy. Immunotherapy. 2017;9(11):929\u201341.","journal-title":"Immunotherapy"},{"issue":"5","key":"654_CR29","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.ijrobp.2011.10.052","volume":"83","author":"D Pak","year":"2012","unstructured":"Pak D, et al. Lhermitte sign after chemo-IMRT of head-and-neck cancer: incidence, doses, and potential mechanisms. Int J Radiat Oncol Biol Phys. 2012;83(5):1528\u201333.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"654_CR30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/hed.20140","volume":"27","author":"WM Leung","year":"2005","unstructured":"Leung WM, Tsang N\u2011M, Chang FT, et al. Lhermitte\u2019s sign among nasopharyngeal cancer patients after radiotherapy. Head Neck. 2005;27:187\u201394.","journal-title":"Head Neck"},{"issue":"10","key":"654_CR31","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1159\/000365539","volume":"37","author":"A O\u2019Reilly","year":"2014","unstructured":"O\u2019Reilly A, et\u00a0al. Lhermitte\u2019s phenomenon and platinum, beware of latency. Oncol Res Treat. 2014;37(10):591\u20134.","journal-title":"Oncol Res Treat"},{"issue":"3","key":"654_CR32","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1200\/JCO.2010.31.1993","volume":"29","author":"A Pompili","year":"2011","unstructured":"Pompili A, et\u00a0al. Symptomatic spinal cord necrosis after irradiation for vertebral metastatic breast cancer. J\u00a0Clin Oncol. 2011;29(3):e53\u2013e6.","journal-title":"J Clin Oncol"},{"issue":"5","key":"654_CR33","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/brain\/119.5.1429","volume":"119","author":"J Bowen","year":"1996","unstructured":"Bowen J, et al. The post-irradiation lower motor neuron syndrome neuronopathy or radiculopathy? Brain. 1996;119(5):1429\u201339.","journal-title":"Brain"},{"issue":"2","key":"654_CR34","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s11060-015-1727-z","volume":"122","author":"D Cachia","year":"2015","unstructured":"Cachia D, et\u00a0al. Myelopathy following intrathecal chemotherapy in adults: a\u00a0single institution experience. J\u00a0Neurooncol. 2015;122(2):391\u20138.","journal-title":"J Neurooncol"},{"issue":"6","key":"654_CR35","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1399-0012.2004.00290.x","volume":"18","author":"IB Resnick","year":"2004","unstructured":"Resnick IB, et al. Spinal epidural lipomatosis following haploidentical allogeneic bone marrow transplantation for non-Hodgkin lymphoma. Clin Transplant. 2004;18(6):762\u20135.","journal-title":"Clin Transplant"},{"key":"654_CR36","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jns.2016.06.002","volume":"367","author":"W Grisold","year":"2016","unstructured":"Grisold W, Grisold A, L\u00f6scher WN. Neuromuscular complications in cancer. J\u00a0Neurol Sci. 2016;367:184\u2013202.","journal-title":"J Neurol Sci"},{"issue":"1","key":"654_CR37","first-page":"20","volume":"9","author":"W Grisold","year":"2017","unstructured":"Grisold W, Grisold A, L\u00f6scher W. Cancer therapy and neuromuscular complications: a mini review. Neurology (ECronicon). 2017;9(1):20\u20136.","journal-title":"Neurology (ECronicon)"},{"issue":"2","key":"654_CR38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0885-3924(05)80024-7","volume":"5","author":"CJ Vecht","year":"1990","unstructured":"Vecht CJ. Arm pain in the patient with breast cancer. J\u00a0Pain Symptom Manage. 1990;5(2):109\u201317.","journal-title":"J. Pain Symptom Manage."},{"issue":"4","key":"654_CR39","doi-asserted-by":"crossref","first-page":"436","DOI":"10.21614\/chirurgia.112.4.436","volume":"112","author":"H-B Orsolya","year":"2017","unstructured":"Orsolya H\u2011B, Coros MF, Stolnicu S, Naznean A, Georgescu R. Does the surgical management of the intercostobrachial nerve influence the postoperatory paresthesia of the upper limb and life quality in breast cancer patients? Chirurgia (Bucur). 2017;112(4):436\u201342.","journal-title":"Chirurgia (Bucur)"},{"issue":"8","key":"654_CR40","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.bjps.2014.04.029","volume":"67","author":"M K\u00e4\u00e4ri\u00e4inen","year":"2014","unstructured":"K\u00e4\u00e4ri\u00e4inen M, Giordano S, Kauhanen S, Helminen M, Kuokkanen H. No need to cut the nerve in LD reconstruction to avoid jumping of the breast: a prospective randomized study. J\u00a0Plast Reconstr Aesthet Surg. 2014;67(8):1106\u201310.","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"7","key":"654_CR41","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/bjs.1800630713","volume":"63","author":"B Gunterberg","year":"1976","unstructured":"Gunterberg B, et\u00a0al. Anorectal function after major resections of the sacrum with bilateral or unilateral sacrifice of sacral nerves. Br J Surg. 1976;63(7):546\u201354.","journal-title":"Br J Surg"},{"issue":"1","key":"654_CR42","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1245\/aso.2002.9.1.41","volume":"9","author":"AD Brooks","year":"2002","unstructured":"Brooks AD, et\u00a0al. Resection of the sciatic, peroneal, or tibial nerves: assessment of functional status. Ann Surg Oncol. 2002;9(1):41\u20137.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"654_CR43","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pmr.2016.08.003","volume":"28","author":"MD Stubblefield","year":"2017","unstructured":"Stubblefield MD. Clinical evaluation and management of radiation fibrosis syndrome. Phys Med Rehabil Clin N Am. 2017;28(1):89\u2013100.","journal-title":"Phys Med Rehabil Clin N Am"},{"issue":"1","key":"654_CR44","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.adro.2017.10.002","volume":"3","author":"SS Sood","year":"2018","unstructured":"Sood SS, et\u00a0al. Brachial plexopathy after stereotactic body radiation therapy for apical lung cancer: dosimetric analysis and preliminary clinical outcomes. Adv Radiat Oncol. 2018;3(1):81\u20136.","journal-title":"Adv Radiat Oncol"},{"issue":"7","key":"654_CR45","first-page":"872","volume":"112","author":"NG Kounis","year":"1975","unstructured":"Kounis NG, Macauley MB, Ghorbal MS. Iliacus hematoma syndrome. Can Med Assoc\u00a0J. 1975;112(7):872\u20133.","journal-title":"Can Med Assoc J"},{"issue":"4","key":"654_CR46","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1102\/1470-7330.2013.0052","volume":"13","author":"N Brejt","year":"2013","unstructured":"Brejt N, et\u00a0al. Pelvic radiculopathies, lumbosacral plexopathies, and neuropathies in oncologic disease: a\u00a0multidisciplinary approach to a\u00a0diagnostic challenge. Cancer Imaging. 2013;13(4):591\u2013601.","journal-title":"Cancer Imaging"},{"issue":"3","key":"654_CR47","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.3171\/2015.7.FOCUS15209","volume":"39","author":"S Capek","year":"2015","unstructured":"Capek S, et\u00a0al. Perineural spread of pelvic malignancies to the lumbosacral plexus and beyond: clinical and imaging patterns. Neurosurg Focus. 2015;39(3):E14.","journal-title":"Neurosurg Focus"},{"issue":"6","key":"654_CR48","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1212\/WNL.39.6.871-a","volume":"39","author":"J Dalmau","year":"1989","unstructured":"Dalmau J, Graus F, Marco M. \u2018Hot and dry foot\u2019 as initial manifestation of neoplastic lumbosacral plexopathy. Neurology. 1989;39(6):871\u20132.","journal-title":"Neurology"},{"issue":"1","key":"654_CR49","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1155\/2012\/658730","volume":"17","author":"RJ Evans","year":"2012","unstructured":"Evans RJ, Watson CP. The hot foot syndrome: evans\u2019 sign and the old way. Pain Res Manag. 2012;17(1):31\u20134.","journal-title":"Pain Res Manag"},{"key":"654_CR50","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1477-7819-6-130","volume":"6","author":"PD Gikas","year":"2008","unstructured":"Gikas PD, et al. Post-radiation sciatic neuropathy: a\u00a0case report and review of the literature. World J Surg Oncol. 2008;6:130.","journal-title":"World J Surg Oncol"},{"key":"654_CR51","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2014-207681","author":"L Jones","year":"2015","unstructured":"Jones L, Bradley L. Late and multifocal presentations of malignant peripheral nerve sheath tumours following radiotherapy. BMJ Case Rep. 2015; https:\/\/doi.org\/10.1136\/bcr-2014-207681 .","journal-title":"BMJ Case Rep."},{"issue":"6","key":"654_CR52","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ana.24951","volume":"81","author":"NP Staff","year":"2017","unstructured":"Staff NP, et al. Chemotherapy-induced peripheral neuropathy: a current review. Ann Neurol. 2017;81(6):772\u201381.","journal-title":"Ann Neurol"},{"issue":"3","key":"654_CR53","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/0284186X.2017.1415462","volume":"57","author":"MJ Ibanez-Julia","year":"2018","unstructured":"Ibanez-Julia MJ, et al. Antineoplastic agents exacerbating Charcot Marie Tooth disease: red flags to avoid permanent disability. Acta Oncol. 2018;57(3):403\u201311.","journal-title":"Acta Oncol"},{"key":"654_CR54","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fphar.2017.00086","volume":"8","author":"N Kerckhove","year":"2017","unstructured":"Kerckhove N, et al. Long-term effects, pathophysiological mechanisms, and risk factors of chemotherapy-induced peripheral neuropathies: a comprehensive literature review. Front Pharmacol. 2017;8:86.","journal-title":"Front Pharmacol"},{"key":"654_CR55","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jocn.2017.07.014","volume":"45","author":"Y Gu","year":"2017","unstructured":"Gu Y, et\u00a0al. Immune mediated neuropathy following checkpoint immunotherapy. J\u00a0Clin Neurosci. 2017;45:14\u20137.","journal-title":"J Clin Neurosci"},{"key":"654_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26070","author":"NA Kolb","year":"2018","unstructured":"Kolb NA, et\u00a0al. The neuromuscular complications of immune checkpoint inhibitor therapy. Muscle Nerve. 2018; https:\/\/doi.org\/10.1002\/mus.26070 .","journal-title":"Muscle Nerve"},{"issue":"9","key":"654_CR57","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1093\/jjco\/hyw090","volume":"46","author":"R Tanaka","year":"2016","unstructured":"Tanaka R, Maruyama H, Tomidokoro Y, Yanagiha K, Hirabayashi T, Ishii A, Okune M, Inoue S, Sekine I, Tamaoka A, Fujimoto M. Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain-Barr\u00e9 syndrome: a\u00a0case report. Jpn J Clin Oncol. 2016;46(9):875\u20138. https:\/\/doi.org\/10.1093\/jjco\/hyw090 .","journal-title":"Jpn J Clin Oncol"},{"issue":"10","key":"654_CR58","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1001\/jamaneurol.2017.1912","volume":"74","author":"JC Kao","year":"2017","unstructured":"Kao JC, et al. Neurological complications associated with anti-programmed death 1 (PD-1) antibodies. JAMA Neurol. 2017;74(10):1216\u201322.","journal-title":"JAMA Neurol."},{"issue":"13","key":"654_CR59","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1016\/j.ejca.2013.04.004","volume":"49","author":"D Binda","year":"2013","unstructured":"Binda D, et al. Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS). Eur J Cancer. 2013;49(13):2910\u20138.","journal-title":"Eur J Cancer"},{"issue":"8","key":"654_CR60","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1212\/WNL.53.8.1660","volume":"53","author":"DR Cornblath","year":"1999","unstructured":"Cornblath DR, et\u00a0al. Total neuropathy score: validation and reliability study. Neurology. 1999;53(8):1660\u20134.","journal-title":"Neurology"},{"key":"654_CR61","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2017-317215","author":"A Shah","year":"2018","unstructured":"Shah A, et al. Incidence and disease burden of chemotherapy-induced peripheral neuropathy in a\u00a0population-based cohort. J Neurol Neurosurg Psychiatr. 2018; https:\/\/doi.org\/10.1136\/jnnp-2017-317215 .","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"issue":"42","key":"654_CR62","doi-asserted-by":"crossref","first-page":"73312","DOI":"10.18632\/oncotarget.20272","volume":"8","author":"G Nayar","year":"2017","unstructured":"Nayar G, et\u00a0al. Leptomeningeal disease: current diagnostic and therapeutic strategies. Oncotarget. 2017;8(42):73312\u201328.","journal-title":"Oncotarget"},{"issue":"3","key":"654_CR63","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ejon.2012.10.005","volume":"17","author":"V Sun","year":"2013","unstructured":"Sun V, et\u00a0al. Toxicities, complications, and clinical encounters during intraperitoneal chemotherapy in 17 women with ovarian cancer. Eur J Oncol Nurs. 2013;17(3):375\u201380.","journal-title":"Eur J Oncol Nurs"},{"key":"654_CR64","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/978-3-642-82025-0_44","volume":"86","author":"O Busse","year":"1983","unstructured":"Busse O, Aigner K, Wilimzig H. Peripheral nerve damage following isolated extremity perfusion with cis-platinum. Recent Results Cancer Res. 1983;86:264\u20137.","journal-title":"Recent Results Cancer Res"},{"issue":"2","key":"654_CR65","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1097\/MPH.0000000000000889","volume":"40","author":"P Ari","year":"2018","unstructured":"Ari P, et\u00a0al. Treatment of transient peripheral neuropathy during chimeric 14.18 antibody therapy in children with neuroblastoma: a case series. J\u00a0Pediatr Hematol Oncol. 2018;40(2):e113\u2013e6.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"12","key":"654_CR66","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S1470-2045(17)30680-0","volume":"18","author":"AT Shaw","year":"2017","unstructured":"Shaw AT, et al. Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial. Lancet Oncol. 2017;18(12):1590\u20139.","journal-title":"Lancet Oncol"},{"key":"654_CR67","first-page":"712040","volume":"2014","author":"Z Kanaan","year":"2014","unstructured":"Kanaan Z, et al. Guillain-Barre syndrome following treatment with Sunitinib Malate. Case Rep Oncol Med. 2014;2014:712040.","journal-title":"Case Rep Oncol Med"},{"issue":"1","key":"654_CR68","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1158\/1078-0432.CCR-13-0541","volume":"20","author":"I Krop","year":"2014","unstructured":"Krop I, Winer EP. Trastuzumab emtansine: a\u00a0novel antibody-drug conjugate for HER2-positive breast cancer. Clin Cancer Res. 2014;20(1):15\u201320.","journal-title":"Clin Cancer Res"},{"key":"654_CR69","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-018-2743-6","author":"S Mariotto","year":"2018","unstructured":"Mariotto S, Ferrari S, Monaco S. Brentuximab vedotin-induced peripheral neuropathy: looking at microtubules. J\u00a0Neurooncol. 2018; https:\/\/doi.org\/10.1007\/s11060-018-2743-6 .","journal-title":"J Neurooncol"},{"issue":"12","key":"654_CR70","first-page":"6947","volume":"37","author":"K Yamanouchi","year":"2017","unstructured":"Yamanouchi K, et al. The relationship between peripheral neuropathy induced by Docetaxel and systemic inflammation-based parameters in patients with breast cancer. Anticancer Res. 2017;37(12):6947\u201351.","journal-title":"Anticancer Res"},{"key":"654_CR71","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejca.2016.12.006","volume":"73","author":"JG Lees","year":"2017","unstructured":"Lees JG, et al. Immune-mediated processes implicated in chemotherapy-induced peripheral neuropathy. Eur J Cancer. 2017;73:22\u20139.","journal-title":"Eur J Cancer"},{"issue":"5","key":"654_CR72","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1212\/WNL.48.5.1234","volume":"48","author":"TT Batchelor","year":"1997","unstructured":"Batchelor TT, et\u00a0al. Steroid myopathy in cancer patients. Neurology. 1997;48(5):1234\u20138.","journal-title":"Neurology"},{"key":"654_CR73","first-page":"217","volume":"5","author":"C Basualto-Alarcon","year":"2014","unstructured":"Basualto-Alarcon C, et al. Sarcopenia and androgens: a link between pathology and treatment. Front Endocrinol (Lausanne). 2014;5:217.","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"4","key":"654_CR74","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1470-2045(11)70328-X","volume":"13","author":"JS Mieog","year":"2012","unstructured":"Mieog JS, et\u00a0al. Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2\u20133 years of tamoxifen: a\u00a0retrospective analysis of the Intergroup Exemestane Study. Lancet Oncol. 2012;13(4):420\u201332.","journal-title":"Lancet Oncol"},{"issue":"4","key":"654_CR75","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/ane.12261","volume":"130","author":"S Hoffmann","year":"2014","unstructured":"Hoffmann S, et\u00a0al. Glucocorticoids in myasthenia gravis\u2014if, when, how, and how much? Acta Neurol Scand. 2014;130(4):211\u201321.","journal-title":"Acta Neurol Scand"},{"issue":"12","key":"654_CR76","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s11908-014-0448-3","volume":"16","author":"S Bhattacharyya","year":"2014","unstructured":"Bhattacharyya S, Darby R, Berkowitz AL. Antibiotic-induced neurotoxicity. Curr Infect Dis Rep. 2014;16(12):448.","journal-title":"Curr Infect Dis Rep"},{"key":"654_CR77","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24648","author":"AI Loochtan","year":"2015","unstructured":"Loochtan AI, Nickolich MS, Hobson-Webb LD. Myasthenia gravis associated with ipilimumab and nivolumab in the treatment of small cell lung cancer. Muscle Nerve. 2015; https:\/\/doi.org\/10.1002\/mus.24648 .","journal-title":"Muscle Nerve"},{"key":"654_CR78","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1212\/WNL.0000000000004359","volume":"89","author":"S Suzuki","year":"2017","unstructured":"Suzuki S. Nivolumab-related myasthenia gravis with myositis and myocarditis in Japan. Neurology. 2017;89:1127\u201334.","journal-title":"Neurology"},{"issue":"50","key":"654_CR79","doi-asserted-by":"crossref","first-page":"e9262","DOI":"10.1097\/MD.0000000000009262","volume":"96","author":"JH Chen","year":"2017","unstructured":"Chen JH, et al. Coexisting myasthenia gravis, myositis, and polyneuropathy induced by ipilimumab and nivolumab in a\u00a0patient with non-small-cell lung cancer: a case report and literature review. Medicine (Baltimore). 2017;96(50):e9262.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"654_CR80","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, et\u00a0al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12(5):489\u201395.","journal-title":"Lancet Oncol"},{"key":"654_CR81","doi-asserted-by":"crossref","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","volume":"4","author":"VE Baracos","year":"2018","unstructured":"Baracos VE, et al. Cancer-associated cachexia. Nat Rev Dis Primers. 2018;4:17105.","journal-title":"Nat Rev Dis Primers"},{"key":"654_CR82","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3389\/fimmu.2017.00992","volume":"8","author":"A Aussy","year":"2017","unstructured":"Aussy A, Boyer O, Cordel N. Dermatomyositis and immune-mediated necrotizing myopathies: a window on autoimmunity and cancer. Front Immunol. 2017;8:992.","journal-title":"Front Immunol"},{"issue":"16","key":"654_CR83","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1042\/BCJ20170032","volume":"474","author":"JM Argiles","year":"2017","unstructured":"Argiles JM, et\u00a0al. Novel targeted therapies for cancer cachexia. Biochem\u00a0J. 2017;474(16):2663\u201378.","journal-title":"Biochem J"},{"key":"654_CR84","first-page":"795242","volume":"2015","author":"A Perel-Winkler","year":"2015","unstructured":"Perel-Winkler A, et al. A case of Docetaxel induced myositis and review of the literature. Case Rep Rheumatol. 2015;2015:795242.","journal-title":"Case Rep Rheumatol"},{"issue":"6","key":"654_CR85","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.semarthrit.2013.11.009","volume":"43","author":"L Spielmann","year":"2014","unstructured":"Spielmann L, et al. Gemcitabine-induced myopathy. Semin Arthritis Rheum. 2014;43(6):784\u201391.","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"654_CR86","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/cas.13022","volume":"107","author":"H Minami","year":"2016","unstructured":"Minami H, et al. Phase I, multicenter, open-label, dose-escalation study of sonidegib in Asian patients with advanced solid tumors. Cancer Sci. 2016;107(10):1477\u201383.","journal-title":"Cancer Sci"},{"issue":"9","key":"654_CR87","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s10067-006-0459-z","volume":"26","author":"Y Yoshidome","year":"2007","unstructured":"Yoshidome Y, et\u00a0al. A case of polymyositis complicated with myasthenic crisis. Clin Rheumatol. 2007;26(9):1569\u201370.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"654_CR88","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/CMR.0000000000000424","volume":"28","author":"Y Muto","year":"2018","unstructured":"Muto Y, et al. Success of rechallenging dabrafenib and trametinib combination therapy after trametinib-induced rhabdomyolysis: a\u00a0case report. Melanoma Res. 2018;28(2):151\u20134.","journal-title":"Melanoma Res"},{"issue":"11","key":"654_CR89","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1634\/theoncologist.2009-0090","volume":"15","author":"HA Burris 3rd","year":"2010","unstructured":"Burris HA 3rd, Hurtig J. Radiation recall with anticancer agents. Oncologist. 2010;15(11):1227\u201337.","journal-title":"Oncologist"},{"key":"654_CR90","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/thorax.56.1.82","volume":"56","author":"AL Stephenson","year":"2001","unstructured":"Stephenson AL, Mackenzie IRA, Levy RD, Road J. Myositis associated graft-versus-host-disease presenting as respiratory muscle weakness. Thorax. 2001;56:82\u20134.","journal-title":"Thorax"},{"issue":"25","key":"654_CR91","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM198312223092508","volume":"309","author":"CI Smith","year":"1983","unstructured":"Smith CI, et al. Myasthenia gravis after bone-marrow transplantation. Evidence for a\u00a0donor origin. N\u00a0Engl J Med. 1983;309(25):1565\u20138.","journal-title":"N Engl J Med"},{"key":"654_CR92","doi-asserted-by":"publisher","DOI":"10.1093\/nop\/npx034","author":"HE Leeper","year":"2017","unstructured":"Leeper HE, Acquaye AA, Bell S, Clarke JL, Forst D, Laack NN, Link MJ, Taylor JW, Armstrong TS. Survivorship care planning in neuro-oncology. Neurooncol Pract. 2017; https:\/\/doi.org\/10.1093\/nop\/npx034 .","journal-title":"Neurooncol Pract"}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10354-018-0654-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-018-0654-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-018-0654-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T22:47:45Z","timestamp":1662072465000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10354-018-0654-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,19]]},"references-count":92,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["654"],"URL":"https:\/\/doi.org\/10.1007\/s10354-018-0654-y","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"value":"0043-5341","type":"print"},{"value":"1563-258X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,19]]},"assertion":[{"value":"9 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"W. Grisold, W. L\u00f6scher, and A. Grisold declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}